FindTrial
Sign In

Comfort with spinal anaesthesia

Comparative study of intrathecal Nalbuphine and intrathecal Fentanyl as adjuvant to 0.5% hyperbaric Bupivacaine in abdominal and lower limb surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024823
Enrollment
60
Registered
2020-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Adjuvants in spinal anaesthesia: O.5mg Nalbuphine and 25 micrograms Fentanyl will be added to 0.5% Bupivacaine in spinal anaesthesia and postoperative analgesia duration ,haemodyna

Sponsors

DRPSIMS RF
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1 and 2 patients Age group of 18-60 years patient willing to give consent patient undergoing abdominal and lower limb surgeries

Exclusion criteria

Exclusion criteria: patient allergic to any anaesthetic drug bleeding disorders ASA grade 3 and 4 patient. not willing for consent

Design outcomes

Primary

MeasureTime frame
To study duration of postoperative analgesia ,haemodynamics and side effects of Nalbuphine and FentanylTimepoint: 24 hours—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Karupothu Rani

DR.PSIMS&RF

doctorvaraprasad@gmail.com9849725560

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026